Fig. 3From: Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinicOverlap of frailty, sarcopenia, and suspected dementia (MMSE score ≤ 23) (a) and overlap of frailty, sarcopenia, and cognitive impairment (MoCA-J ≤ 25) (b). Numbers indicates the number of patients included in the areaBack to article page